首页> 美国卫生研究院文献>Aging (Albany NY) >Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation
【2h】

Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation

机译:肾移植后受体间质纤维化和肾小管萎缩伴亚临床炎症mRNA表达谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Interstitial fibrosis and tubular atrophy (IFTA) with inflammation (IFTA-I) is strongly correlated with kidney allograft failure. Diagnosis of IFTA-I accurately and early is critical to prevent graft failure and improve graft survival. In the current study, through analyzing the renal allograft biopsy in patients with stable function after kidney transplantation (STA), IFTA and IFTA-I group with semi-supervised principal components methods, we found that CD2, IL7R, CCL5 based signature could not only distinguish STA and IFTA-I well, but predict IFTA-I with a high degree of accuracy with an area under the curve (AUC) of 0.91 (P = 0.00023). Additionally, IRF8 demonstrated significant differences among STA, IFTA and IFTA-I groups, suggesting that IRF8 had the capacity to discriminate the different classifications of graft biopsies well. Also, with Kaplan-Meier and log-rank methods, we found that IRF8 could serve as the prognostic marker for renal graft failure in those biopsies without rejection (AUC = 0.75) and the recipients expressing high had a higher risk for renal graft loss (P < 0.0001). This research may provide new targets for therapeutic prevention and intervention for post-transplantation IFTA with or with inflammation.
机译:间质纤维化和肾小管萎缩(IFTA-I)与炎症(IFTA-I)与同种异体肾功能衰竭密切相关。准确,早期诊断IFTA-I对于预防移植失败和提高移植存活率至关重要。在本研究中,通过使用半监督主成分方法分析肾移植(STA),IFTA和IFTA-I组功能稳定的患者的肾同种异体移植活检,我们发现基于CD2,IL7R,CCL5的签名不仅可以可以很好地区分STA和IFTA-I,但是可以以0.91的曲线下面积(AUC)高度准确地预测IFTA-I(P = 0.00023)。此外,IRF8在STA,IFTA和IFTA-I组之间显示出显着差异,这表明IRF8具有很好地区分移植物活检分类的能力。同样,通过Kaplan-Meier和log-rank方法,我们发现IRF8可以作为那些没有排斥反应的活检组织中肾移植失败的预后标志物(AUC = 0.75),表达高的接受者有较高的肾移植失败风险( P <0.0001)。这项研究可能为有或有炎症的移植后IFTA的治疗预防和干预提供新的靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号